Read here for an analysis on Humacyte (HUMA) stock post-Symvess approval, potential upside in revenue generation, and ...

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), a leading biotechnology company specializing in cystic fibrosis (CF) treatments, has been making significant strides in expanding its therapeutic portfolio ...

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

Larimar Therapeutics, Inc. (NASDAQ:LRMR), with a market capitalization of $228 million, is a clinical-stage biopharmaceutical ...

As we age, our skin undergoes various transformations that can leave us feeling less confident about our appearance. Fine ...

President Donald Trump’s pick for secretary of agriculture -- was asked about tariffs, bird flu, the effect of mass ...

The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and ...

Users of First Aid Beauty, a skin care company based out of Massachusetts, learned of the voluntary recall in December when ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

Merck and Eisai reported new data for a drug regimen of Keytruda and Lenvima. Elsewhere, AstraZeneca expanded in Canada and ...

A flurry of scientific gatherings and panels across federal science agencies were canceled on Wednesday, at a time of ...

Abeona Therapeutics Inc.'s promising gene therapy for RDEB, potential FDA approval, undervalued stock, and key risks. Click ...